I. Chen
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Renal cell carcinoma treatment 5
- Prostate Cancer Treatment and Research 2
-
- Cancer Genomics and Diagnostics 3
- Breast Cancer Treatment Studies 1
- Co-authors
- Robert J. Motzer (5 shared papers)Robert A. Figlin (2 shared papers)Michael Baum (2 shared papers)Dongrui R. Lu (1 shared paper)Brian I. Rini (1 shared paper)Santosh Hariharan (1 shared paper)Martin Gore (1 shared paper)S. T. Kim (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)JNCI Journal of the National Cancer Institute (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
I. Chen
9 papers receiving 579 citations
I. Chen's Hit Papers
Peers
Comparison fields: 5 of 48
- Cancer Research 203
- Pulmonary and Respiratory Medicine 422
- Oncology 234
- Molecular Biology 322
- Cardiology and Cardiovascular Medicine 85
Countries citing papers authored by I. Chen
This map shows the geographic impact of I. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Chen more than expected).
Fields of papers citing papers by I. Chen
This network shows the impact of papers produced by I. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Chen. The network helps show where I. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside I. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Hit paper breakdown → | 2011 | 446 |
| 2 | 2007 | 71 | |
| 3 | 2011 | 33 | |
| 4 | 2007 | 13 | |
| 5 | 2006 | 10 | |
| 6 | 2007 | 6 | |
| 7 | 2007 | 6 | |
| 8 | 2020 | 1 | |
| 9 | 2004 | 1 |
About I. Chen
I. Chen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Economics and Econometrics and Oncology, having authored 9 papers that have together received 587 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Cancer Genomics and Diagnostics (3 papers), Economic and Financial Impacts of Cancer (3 papers), Renal and related cancers (3 papers), Prostate Cancer Treatment and Research (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Advanced Radiotherapy Techniques (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Cancer Research (203 citations), Pulmonary and Respiratory Medicine (422 citations), Oncology (234 citations), Molecular Biology (322 citations) and Cardiology and Cardiovascular Medicine (85 citations). I. Chen has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Robert J. Motzer, Robert A. Figlin, Michael Baum, Dongrui R. Lu, Brian I. Rini, Santosh Hariharan, Martin Gore, S. T. Kim, Thomas E. Hutson and M. Dror Michaelson. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.